Singapore markets close in 51 minutes

Relay Therapeutics, Inc. (RLAY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.95-0.01 (-0.17%)
At close: 04:00PM EDT
6.00 +0.05 (+0.84%)
After hours: 05:09PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.96
Open6.02
Bid5.93 x 200
Ask5.96 x 100
Day's range5.78 - 6.07
52-week range5.78 - 13.32
Volume1,004,014
Avg. volume1,190,512
Market cap780.515M
Beta (5Y monthly)1.63
PE ratio (TTM)N/A
EPS (TTM)-2.79
Earnings date02 May 2024 - 06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est23.05
  • GlobeNewswire

    Relay Therapeutics to Participate in Upcoming Investor Conferences

    CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in three upcoming fireside chats: Stifel 2024 Virtual Targeted Oncology Forum on Wednesday, April 17, 2024 at 1:00 p.m. ETThe Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024 at 11:30 a.m.

  • Insider Monkey

    11 Oversold Biotech Stocks To Buy Right Now

    In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]

  • Zacks

    Does Relay Therapeutics, Inc. (RLAY) Have the Potential to Rally 146.52% as Wall Street Analysts Expect?

    The mean of analysts' price targets for Relay Therapeutics, Inc. (RLAY) points to a 146.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.